BVF PARTNERS L P/IL Insider Trading $SUPG Astex Pharmaceuticals, Inc
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in KENT INTERNATIONAL HOLDINGS INC ($CRTQ) and 10% Owner in LIGAND PHARMACEUTICALS INC ($LGND) and 10% Owner in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in REPLIGEN CORP ($RGEN) and 10% Owner in AVIGEN INC \DE ($AVGN) and 10% Owner in NEUROCRINE BIOSCIENCES INC ($NBIX) and 10% Owner in Astex Pharmaceuticals, Inc ($SUPG) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ ($NTII) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARRAY BIOPHARMA INC ($ARRY) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ICAGEN INC ($ICGN) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in Celera CORP ($CRA) and 10% Owner in ABBOTT BIOTHERAPEUTICS CORP ($FACT).
BVF PARTNERS L P/IL in Astex Pharmaceuticals, Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 5,583,399 shares
Latest Transaction: Apr 21 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in Astex Pharmaceuticals, Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FACT, ARQL, ARRY, SUPG, AVGN, CAPS, CBIO, CRA, CCXI, DVAX, CRXX, ICGN, CRTQ, LGND, NTII, NBIX, RGEN, RIGL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21 2010 | SUPG | Astex Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 3.54 | 61,000 | 216,025 | 5,583,399 | 5.6 M to 5.6 M (-1.08 %) |
| Apr 21 2010 | SUPG | Astex Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 3.54 | 18,000 | 63,745 | 5,644,399 | 5.7 M to 5.6 M (-0.32 %) |
| Apr 21 2010 | SUPG | Astex Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 3.54 | 25,000 | 88,535 | 5,662,399 | 5.7 M to 5.7 M (-0.44 %) |
| Apr 21 2010 | SUPG | Astex Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 3.58 | 39,000 | 139,484 | 5,687,399 | 5.7 M to 5.7 M (-0.68 %) |
| Apr 21 2010 | SUPG | Astex Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 3.58 | 11,000 | 39,342 | 5,726,399 | 5.7 M to 5.7 M (-0.19 %) |
| Apr 21 2010 | SUPG | Astex Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 3.58 | 16,000 | 57,224 | 5,737,399 | 5.8 M to 5.7 M (-0.28 %) |
Page: 1